STD Med, Pavilion announce joint investment to launch Saphena Medical
Published on February 12, 2013 at 12:40 AM
Pavilion Medical Innovations L.L.C. of Norwell, MA and STD Med, Inc. of Stoughton, MA are pleased to announce a joint investment to launch Saphena Medical, Inc., a new cutting edge medical device company focused on Endoscopic Vein Harvesting technologies. Its OnePass™ platform delivers single-step, minimally-invasive harvesting of veins used for coronary artery bypass grafting. The company recently raised $3 million in Series A funding to take the OnePass™ platform through regulatory clearance.
Saphena Medical, located at the STD Med Innovation Center in West Bridgewater, MA is the fifth start-up technology company for OEM STD Med, Inc. and also the fifth for Pavilion founders, who most recently sold Vortex Medical to AngioDynamics.
Pavilion founder Michael Glennon , who will serve as the President of Saphena Medical says, "This funding and our close working relationship with the experts at STD Med will enable Saphena Medical to rapidly move our game changing platform technology through all the processes required for commercialization". Andrea Patisteas , Senior Executive VP at STD Med said, "We are excited to join with Pavilion and share resources and expertise to successfully bring Saphena Medical's technology to market." "We both bring a lot to the table," said Steven Tallarida , President of STD Med. "Medical device incubators need to get their products to market faster and more cost effectively and that's how Mike Glennon 's model works."